Burundi vs Central African Republic: Average cost of multi drug-resistant tuberculosis treatment
Burundi
1,051 constant 2022 US$
in 2024
Central African Republic
1,043 constant 2022 US$
in 2024
Burundi rank
45th
Central African Republic rank
46th
Average cost of multi drug-resistant tuberculosis treatment over time
- Burundi
- Central African Republic
How they compare
Burundi currently reports 1,051 constant 2022 US$ against 1,043 constant 2022 US$ in Central African Republic, a difference of 8 constant 2022 US$.
The two have swapped places 3 times across 7 shared years of data; in 2017 it was Central African Republic ahead.
Burundi ranks 45th and Central African Republic ranks 46th of 92 countries.
Across the 2 decades both report, Burundi averaged higher in 1 and Central African Republic in 1.
Head to head by decade
| Decade | Burundi | Central African Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,711 constant 2022 US$ | 1,461 constant 2022 US$ | 249.67 constant 2022 US$ | Burundi |
| 2020s | 1,025 constant 2022 US$ | 1,080 constant 2022 US$ | 55.25 constant 2022 US$ | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Burundi or Central African Republic?
- Burundi, at 1,051 constant 2022 US$ against 1,043 constant 2022 US$ in Central African Republic as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Burundi and Central African Republic?
- 8 constant 2022 US$, with Burundi ahead.
- How many years of comparable data are there for Burundi and Central African Republic?
- 7 years are reported by both, from 2017 to 2024.
- How do Burundi and Central African Republic rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Burundi ranks 45th and Central African Republic ranks 46th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.